2014 Honda Accord Sport on 2040-cars

Auto blog

Rumors abound over Honda's mid-engined 'Small NSX'

The "baby NSX" lately in the news has been in Honda's idea cloud since before the 2008 global financial rift. The company called it the "Small NSX" and reports said it "will really be a scaled-back version" of Acura's exotic, including the mid-engine layout and a variation of the hybrid SH-AWD. It even had a price: $50,000 to $60,000. So more than seven years on, when a series of patent images materialize for what looks like an NSX-inspired Honda sports car, it doesn't prove anything, but it fits. Motoring reports that the Small NSX will sit at the top of a lineup of three mid-engined sports cars intended for the Honda brand - but note that Motoring is based in Australia, where our Acura NSX is sold as a Honda. This Small NSX would be a "radical replacement" for the Honda S2000 that ended production in 2009. Beneath it will be a global version of the S660 roadster that could come here as an S1000 with 125 horsepower. The Civic Type R and a much sportier, reimagined CR-Z will put some long forgotten handling chops at other price points in the model mix. Motoring's sources say the Small NSX design work is, "for all intents and purposes, completed." The consistent rumor regarding engine is the 306-hp 2.0-liter turbo VTEC used in the Civic Type R. One electric motor will be in back to help move the rear wheels, two electric motors will hang on the front axle. Overall power output is put at around 400 hp, with 330 hp of that coming from the ICE, working through a nine-speed dual-clutch transmission. An aluminum frame with aluminum and carbon fiber parts will discourage heft, the final product at aiming at a weight under 3,100 pounds. Its price should be competitive with its intended target, the Porsche Cayman. The 2018 Detroit Auto Show is where we might see it, before it goes into production later that year at Honda's Performance Manufacturing Center in Marysville, OH. Related Video: News Source: Motoring Green Acura Honda Coupe Hybrid Performance honda nsx

Honda Civic Tourer caught testing ahead of 2014 launch

Honda showed off its Civic Tourer concept at the Geneva Motor Show in March, and at that time, we were told that a production version would be coming to market in the very near future. Obviously, the sleek lines of the concept car will be dumbed down slightly for consumers, but that doesn't mean the Civic wagon will be a bland machine. The Euro-spec Civic's angular front end looks like it will blend nicely with the rakish rump that we saw on the concept.
Our sources suggest that not only will the Civic Tourer be a class-leader in terms of cargo capacity, but it will likely be a pretty engaging car from behind the wheel, as well. Honda is hoping that the Tourer will account for roughly 20 percent of all European Civic sales after it goes on sale.
Expect to see the production car debut at the Frankfurt Motor Show this September, with the first customers taking delivery in early 2014. In the meantime, have a look at the camouflaged swoopy wagon from all angles in our gallery above.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.